Symposium: (World Allergy Congress)

Oral Abstract Session 1: Allergen Immunotherapy 1

Gran Cancún 1 (Cancún Center)

Chairpersons: Noel Rodriguez-Perez (Mexico) and Enrico Compalati (Italy)

12:45 - 13:00

2156: Ultra-Rush Specific Immune Therapy with Depigmented and Polymerized Allergen Extracts Is Effective and Safe in Patients with Severe SAR Highly Sensitized Against Pollen Allergens Ulrich Amon (Germany)

13:00 - 13:15

2157: Dose Optimizing Study of A Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test | Angelika Sager (Germany)

13:15 - 13:30

2158: Double-Blind Study on The Use of Transfer Factor (TF) Combined With Sublingual Immunotherapy in Management of Patients With Allergic Rhinitis in Mexican Population | María Isabel Rojo Gutiérrez (Mexico)

13:30 - 13:45

2159: The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults when Treated With Standardised Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials | Jens Strodl Andersen (Denmark)

13:45 - 14:00

2160: Post-treatment, long-term clinical efficacy of a 300 IR sublingual tablet of 5-grass pollen allergen extract in adults with grass pollen-induced allergic rhinoconjunctivitis Michèle Lheritier-Barrand (France)

14:00 - 14:15

2161: Escherichia coli Heat-labile Enterotoxin (LTS61K) Modulates Dendritic Cell Function and Attenuates Airway Inflammation in Mouse Model of Allergic Asthma | Jiu_yao Wang (Taiwan)

Oral Abstract Session 2: Allergen Structure 1

Gran Cancún 2 (Cancún Center)

Chairpersons: Enrique Fernandez-Caldas (Spain) and Oussama Abou Chakra (France)

12:45 - 13:00

2162: Comprehensive Detection of Allergens in Grass Pollen Extracts by Mass Spectrometry | Steffen Augustin (Germany)

13:00 - 13:15

2163: Gene Expression Pattern of Arabidopsis EXPB1, a Non-Allergenic Homologue of Grass Group 1 Pollen Allergens | Prem Bhalla (Australia)

13:15 - 13:30

2164: Comprehensive Expression of Recombinant House Dust Mite Allergens for Component-Resolved Diagnosis | Yoshiharu Watakabe (Japan)

13:30 - 13:45

2165: A Bioinformatic Approach to Allergen Nomenclature Applied to Allergens From the Non-Biting Midge Chironomus Thummi Thummi | Heimo Breiteneder (Austria)

13:45 - 14:00

2166: Pollen Allergens Differ From Non-Allergenic Pollen Proteins by Their Lower Extent of Evolutionary Conservation | Christian Radauer (Austria)

14:00 - 14:15

2167: Sensitization to Betula Verrucosa and Rbet v1 in Spain | Barbara Cases (Spain)

Oral Abstract Session 3: Allergic Models of Inflammation

Gran Cancún 3 (Cancún Center)

Chairpersons: Giovanni Melioli (Italy) and Harald Renz (Germany)

12:45 - 13:00

2168: Common and Rare Variation In the T Helper 2 Gene Pathway Predicts Allergic Asthma Phenotypes | Rebecca Slager (US)

13:00 - 13:15

2169: Role of Myeloid Derived Suppressor Cells in Asthma Srinivas Nagaraj (US)

13:15 - 13:30

2170: Mir-150 Suppresses Lung Inflammation In A Mouse Model of Experimental Asthma | Jia-Wang Wang (US)

13:30 - 13:45

2171: Serine Protease Inhibitor Attenuates OVA Induced Inflammation In Mouse Model of Allergic Airway Disease | Sanjay Saw (India)

13:45 - 14:00

2172: Potential Role of Scavenger Receptors in Human Mast Cell Cytokine Response to Oxidized LDL Francesca Levi-Schaffer (Israel)

Oral Abstract Session 4: Allergic Rhinitis

Gran Cancún 4 (Cancún Center)

Chairpersons: Mark Dykewicz, MD (US) and Yeong Ho Rha (South Korea)

12:45 - 13:00

2173: Allergic Rhinitis to Ragweed Pollen | Ioana Corina Bocsan (Romania)

13:00 - 13:15

2174: Ragweed Allergy – What Role Does It Play in Bavaria? | Mareike McIntyre (Germany)

13:15 - 13:30

2175: Nasal Nitric Oxide and Nasal Polyposis As Determinants of Asthma Control | Enrico Heffler (Italy)

13:30 - 13:45

2176: Peak Nasal Inspiratory Flow Levels In Children with Allergic Rhinitis and Their Health Related Quality of Life (HRQL) | Major K. Nagaraju (India)

13:45 - 14:00

2177: Exhaled Nitric Oxide and Airway Function in Seasonal Allergic Rhinitis | Masanobu Shinogami (Japan)

Oral Abstract Session 5: Atopic Dermatitis 1

Gran Cancún 5 (Cancún Center)

Chairpersons: Prof. Dr. Peter Schmid-Grendelmeier (Switzerland) and Atsuo Urisu (Japan)

12:45 - 13:00

2178: Contribution of IL-33 and Nuocyte to Experimental Allergic Dermatitis | Yasutomo Imai (Japan)

13:00 - 13:15

2179: S100A8/A9, A DAMP Molecule Activated by IL-17 and House Dust Mite Is Upregulated In Atopic Dermatitis Kwang Hoon Lee (South Korea)

13:15 - 13:30

2180: Arginase I Levels Are Decreased In Pediatric Patients with Atopic Dermatitis | Victoria Dimitriades (US)

13:30 - 13:45

2181: Polyprenol Could Prevent Loss of Filaggrin In Epithelial Cells In Atopic Dermatitis | Ivans S Kuznecovs (Latvia)

13:45 - 14:00

2182: Role of Sweating On Impaired Skin Barrier Functions In Atopic Dermatitis | Aya Takahashi (Japan)

14:00 - 14:15

2183: Reduced Occurrence of Early Atopic Dermatitis Due to Immunoactive Prebiotics Among Low Atopy Risk Infants | Christoph Grüber (Germany)

Oral Abstract Session 6: Conjunctivitis

Cozumel 2 (Cancún Center)

Chairpersons: Sergio Bonini (Italy) and Leonard Bielory (US)

12:45 - 13:05

: Test Title

13:05 - 13:20

2184: Ocular Signs and Symptoms Elicited by a Naturalistic Allergen Challenge in An Environmental Exposure Chamber Model Versus a Direct Allergen Instillation Model | Michael S. Blaiss (US)

13:20 - 13:35

2185: Increased Frequency of CD4+ CD25+ FOXP3- in Allergic Conjunctivitis Patients | Jorge Galicia-Carreón (Mexico)

13:35 - 13:50

2186: Increased Frequency of CD4+ CCR4+ CCR9+ Cells in Patients with Allergic Conjunctivitis | Miguel E Alonso-Sánchez (Mexico)

13:50 - 14:05

2187: Long-Term IFN-g Treatment Alters Allergic Inflammation-Associated Gene Expression in Conjunctival Fibroblasts | Naoko Okada (Japan)

14:05 - 14:20

2188: Hyperosmolar Conjunctival Provocation Test (HCPT) in the Evaluation of Ocular Symptoms Nelson Rosario (Brazil)

14:20 - 14:35

2189: Tear IFN-g Is Increased After Sublingual Immunotherapy in Allergic Conjunctivitis Patients and Correlates with Clinical Improvement | Gustavo Aguilar-Velazquez (Mexico)

Oral Abstract Session 7: Immunodeficiency

Isla Mujeres (Cancún Center)

Chairpersons: John Sleasman (US) and Mark Ballow (US)

12:45 - 13:00

2190: Anxiety and Depression in Patients with Variable Common Immunodeficiency in the Service of Allergy and Clinical Immunology - Centro Médico Nacional Siglo XXI | Nelva Guillén (Mexico)

13:00 - 13:15

2191: Transient Immune Reconstitution Following Gastric Bypass Surgery with Ensuing Sjogren's Syndrome | John Kim (US)

13:15 - 13:30

2192: Computed Tomography Findings Consistent with Rhinosinusitis, Clinical Correlation and Quality of Life in Patients with Common Variable Immunodeficiency. Original Article | Elizabeth Mendieta (Mexico)

13:30 - 13:45

2193: Subcutanous Vivaglobulin® Replacement Therapy in Patients with Primary Immunodeficiency Confers Protective Antibody Titers to Major Organisms | Doanh Nguyen (US)

13:45 - 14:00

2194: Case Report: Recurrent Mucocutaneous Candidiasis and Recurrent Diarrhea by Gram Negative Bacteria | Juan Aldave Becerra (Peru)

14:00 - 14:15

2195: Bronchiectasis: Localization and Characteristics, Identified by Using a High Resolution CT Scan in Adults with Common Variable Immunodeficiency | Laura Mendoza (Mexico)

Oral Abstract Session 8: Indoor Risk Factors for Asthma

Tulum (Cancún Center)

Chairpersons: Thomas Platts-Mills (US) and Myron Zitt (US)

12:45 - 13:00

2196: The Relationship of Pets, Vitamin D and IgE Concentrations to Upper Respiratory Infections In the First Year of Life | Dennis Ownby (US)

13:00 - 13:15

2197: Prevalence of Cockroach and Mouse Sensitization Among Children Hospitalized for Wheezing and Asthma | Terri Moncrief (US)

13:15 - 13:30

2198: Is Pet Ownership Associated with Higher Vitamin D? | Christine Cole Johnson (US)

13:30 - 13:45

2199: Sick Building Syndrome (SBS) Among Workers of Two Buildings and Exposure to Indoor Fungal Allergens in Rio De Janeiro, Brazil | Jose Laerte Boechat (Brazil)

13:45 - 14:00

2200: Asthma Among Office Workers and Exposure to Chemical and Biological Indoor Pollutants Jose Laerte Boechat (Brazil)

14:00 - 14:15

2201: Taxonomic Identification of the House Dust Mites Associated to Allergic Patients In Six Locations From Mexico | Naomi Cuervo (Cuba)

Oral Abstract Session 9: Mechanisms of Asthma

Xcaret (Cancún Center)

Chairpersons: Daniel Jackson (US) and Bradley Undem (US)

12:45 - 13:00

2202: EGCG Down-Regulates Mucin Gene Expression Through the MAPK Signaling Pathway in Asthma | Yong-Dae Kim (South Korea)

13:00 - 13:15

2203: Enhancer of Zeste Homolog 2: A Pivotal Role in Pulmonary Artery Smooth Muscle Cell Proliferation | Salman Aljubran (US)

13:15 - 13:30

2204: The Features of Airway Remodeling Are More Severe in Female Mice | Masahide Takeda (Japan)

13:30 - 13:45

2205: Ovalbumin-Induced Bronchial Asthma Is Compromised in Apoptosis Signal-Regulating Kinase-Deficient Mice | Junichiro Mizuguchi (Japan)

13:45 - 14:00

2206: Role of the CC−Chemokine Receptor CCR9 In the Regulation of Inflammatory Process During Allergic Airway Inflammation | Cynthia López-Pacheco (Mexico)

14:00 - 14:15

2207: Serum IL6 and Soluble IL6R Are Correlated with Lung Function In Non-Hispanic Whites with Asthma | Gregory Hawkins (US)

Oral Abstract Session 10: Sublingual Immunotherapy 1

Costa Maya 1 (Cancún Center)

Chairpersons: Moises Calderon and Peter Creticos (US)

12:45 - 13:00

2208: Safety and Dose-dependent Efficacy of a Novel Ragweed Allergen Immunotherapy Tablet in North American and European Patients: Preliminary Findings | Hendrik Nolte (US)

13:00 - 13:15

2209: Economic Evaluation of Grass Tablets for Immunotherapy (Oralair) Compared to Placebo in Adults and Children in Italy | Amerigo Cicchetti (Italy)

13:15 - 13:30

2210: The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults with Allergic Rhinitis | Karl-Christian Bergmann (Germany)

13:30 - 13:45

2211: Efficacy of Immnunotherapy with An Oral Bacterial Lysate and Vitamin C In the Primary Prevention of Acute Respiratory Tract Infections In Children Luciano Cortigiani (Argentina)

13:45 - 14:00

2212: Impact of Pollen Exposure on the Treatment Effect of Ragweed and Grass Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: Preliminary Findings | Sandra Gawchik (US)

14:00 - 14:15

2213: Efficacy of Timothy Grass Allergy Immunotherapy Tablet (AIT) Treatment in Canadian Children and Adults with Grass Pollen-Induced Allergic Rhinoconjunctivitis (ARC) | Jacques Hebert (Canada)

Oral Abstract Session 11: Urticaria and Angioedema

Costa Maya 2 (Cancún Center)

Chairpersons: David Lang (US) and Jonathan Bernstein (US)

12:45 - 13:00

2214: The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment In Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Dorottya Csuka (Hungary)

13:00 - 13:15

2215: Pre-Procedural Administration of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prevention of Hereditary Angioedema (HAE) Attacks After Medical, Dental, or Surgical Procedures David Mariano (US)

13:15 - 13:30

2216: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Treatment of Hereditary Angioedema (HAE) Attacks Marc Riedl (US)

13:30 - 13:45

2217: Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant | Maria Concetta Siani (Italy)

13:45 - 14:00

2218: Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist, in Patients with Hereditary Angioedema Due to C1-INH Deficiency | Konrad Bork (Germany)

14:00 - 14:15

2219: Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNFα and MMP-9 Release | Sidsel Falkencrone (Denmark)

Oral Abstract Session 12: Food & Drug Allergy: Late-Breakers

Gran Cancún 1 (Cancún Center)

Chairpersons: Daniel Yerly (Switzerland) and Emilia María Hidalgo Castro

12:45 - 13:00

3157: DELAYED- TYPE HYPERSENSITIVITY TO AMINOPENICILLINS: “HANDS DESQUAMATION SYNDROME” | Lizette del Carmen Miguel Polo (Spain)

13:00 - 13:15

3158: Influence of Transglutaminase and the Reducing Agent Glutathione in the Gastric Digestion and Immunogenicity of Beta-Lactoglobulin Mariana Battaglin Villas-Boas (Brazil)

13:15 - 13:30

3159: Immediate and no immediate reactions induced by iodinated contrast medium nonionic among hospitalized patients: incidence and severity | Martín Bedolla-Barajas (Mexico)

13:30 - 13:45

3160: Severe Cutaneus Drug Reactions: Description of a Serie Cases | Fátima Fernandes (Brazil)

14:00 - 14:15

3162: Frequency of Sensitization for Food and Aero-Allergens in Patients Recieved in a Venezuelan Laboratory During 2010-2011 Period Cristina Najm (Venezuela)

Oral Abstract Session 13: Allergen Structure 2

Gran Cancún 2 (Cancún Center)

Chairpersons: Heimo Breiteneder (Austria) and Barbara Cases (Spain)

12:45 - 13:00

3163: Proteomic and Immunological Characterization of Ragweed Allergens | Steffen Augustin (Germany)

13:00 - 13:15

3164: Proteomic Analysis of Major and Minor Allergens From Isolated Pollen Cytoplasmic Granules | Oussama Abou Chakra (France)

13:15 - 13:30

3165: Cross-Reactivity Between Olive Pollen and 3 Species of Grasses in Madrid, Spain | Enrique Fernandez-Caldas (Spain)

13:30 - 13:45

3166: Molecular Properties and Immunological Reactivity of Arabidopsis EXPB1, a Non-Allergenic Homologue of Grass Group 1 Allergens | Mohan Singh (Australia)

13:45 - 14:00

3167: Protein-protein interactions determine IgE reactivity to polygalacturonase from Cupressus sempervirens pollen | Youcef Shahali (France)

14:00 - 14:15

3168: Grafting of Bet v 1 Epitopes Onto Its Homologue Api g 1 Reveals Patient-Specific IgE Recognition Profiles | Barbara Gepp (Austria)

Oral Abstract Session 14: Anaphylaxis

Gran Cancún 3 (Cancún Center)

Chairpersons: F. Estelle R. Simons (Canada) and Felicidad Cua-Lim (Philippines)

12:45 - 13:00

3169: Immunologic Evaluation of the Patients with Ranitidine Anaphylaxis | Hyun-Jung Jin (South Korea)

13:00 - 13:15

3170: Body Mass Index (BMI) and Immediate (“Stat”) Dose of Epinephrine IM (epi IM) Needed to Treat Subcutaneous Allergen Immunotherapy (SCIT) Systemic Reactions (SRs) | Michel Alkhalil (US)

13:15 - 13:30

3171: Muscle Relaxant Induced Allergic Reactions | Gyu-Young Hur (South Korea)

13:30 - 13:45

3172: Features of 51 Patients with Perioperative Anaphylaxis History | Laila Sabino Garro (Brazil)

13:45 - 14:00

3173: Drug Induced Anaphylaxis In A University Hospital In Sao Paulo, Brazil | Marcelo Vivolo Aun (Brazil)

14:00 - 14:15

3174: Analysis of Anaphylactic Reactions to Biological Agents Reported to the Italian Pharmacovigilance Database Giovanna Zanoni (Italy)

Oral Abstract Session 15: Global Asthma Epidemiology

Gran Cancún 4 (Cancún Center)

Chairpersons: Jing Li (China) and Gailen Marshall (US)

12:45 - 13:00

3175: Recurrent Wheezing In Infancy: Epidemiological Changes Between EISL Phase I and III | Herberto Jose Chong Neto (Brazil)

13:00 - 13:15

3176: Asthma Admission Rates in Germany: An Analysis of the Nationwide DRG-Statistic of the Year 2009 | Maria Weyermann (Germany)

13:15 - 13:30

3177: Prevalence and Classification of Asthma In Freshmen Students of A Guatemalan University and Its Relationship with Aeroallegens Sensitization | Juan Pablo Maselli (Guatemala)

13:30 - 13:45

3178: Asthma Mortality in Brazil (1998-2006) Adelmir Souza-Machado (Brazil)

13:45 - 14:00

3179: Dose Response Relationship Between Ascaris Sensitisation and Atopy and Bronchial Hyper-Responsiveness but Not Allergic Diseases in Black South Africans | Michael Levin (South Africa)

14:00 - 14:15

3180: Association of Matrix Metalloproteinase-7 and -12 Genes Polymorphisms with Asthma: A Case-Control Study of MMP-7 and -12 In a Japanese Population | Fumiya Yamaide (Japan)

Oral Abstract Session 16: Hereditary Angioedema

Gran Cancún 5 (Cancún Center)

Chairpersons: Michael Frank (US) and Bruce Zuraw (US)

12:45 - 13:00

3181: Hereditary Angioedema and Normal C1-Inhibitor (HAE Type III): A Novel Mutation In the Coagulation Factor 12 Gene | Konrad Bork (Germany)

13:00 - 13:15

3182: Immuno-Safety of Recombinant Human C1 Inhibitor in Patients with Hereditary Angioedema: An Integrated Analysis Anurag Relan (Netherlands)

13:15 - 13:30

3183: Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks Marc Riedl (US)

13:30 - 13:45

3184: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prophylaxis of Hereditary Angioedema (HAE) Attacks William Lumry (US)

13:45 - 14:00

3185: The Efficacy and Safety of Human Plasma-Derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Henriette Farkas (Hungary)

14:00 - 14:15

3186: Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant | Ramon Lleonart (Spain)

Oral Abstract Session 17: Immunomodulators

Cozumel 2 (Cancún Center)

Chairpersons: Jorge Kalil (Brazil) and Anthony Frew (United Kingdom)

12:45 - 13:00

3187: Modulation of Human Basophilic Responses by a Fibroleukin-Allergen Fusion Protein | Maaike Dooper (Norway)

13:00 - 13:15

3188: Immunogenicity and Safety Aspects of Adeno-Associated Virus–Like Particles (AAVLPs) As Carriers for B-Cell Vaccines | Erika Jensen-Jarolim (Austria)

13:15 - 13:30

3189: M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy Cornelia Schultz (Austria)

13:30 - 13:45

3190: Neisseria Meningitidis Derived Proteoliposome As An Adjuvant for Allergen Vaccines | Wendy Ramírez González (Cuba)

13:45 - 14:00

3191: Immunomodulatory Effects of Manumycin-Type Antibiotics On Human Macrophages | Ilja Striz (Czech Republic)

Oral Abstract Session 18: Inhaled Corticosteroids for Asthma

Isla Mujeres (Cancún Center)

Chairpersons: Diana Deleanu (Romania) and Stanley Szefler (US)

12:45 - 13:00

3192: A Post-Hoc Analysis of Asthma Control and Lung Function Following Treatment with Ciclesonide 80 µg HFA-MDI Twice Daily In Subjects with Mild-to-Moderate Persistent Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol | Eli Meltzer (US)

13:00 - 13:15

3193: The Particle Size of Mometasone Furoate 100 Mcg and 200 Mcg Dry Powder Formulations | Robert Berger (US)

13:15 - 13:30

3194: Clinical Efficacy of Once-Daily Mometasone Furoate in Children with Persistent Asthma Switched From Treatment with Fluticasone Propionate Ariel Teper (US)

13:30 - 13:45

3195: Inhaled Mometasone Furoate Improved Efficacy in Pediatric Asthma Patients Regardless of Previous Inhaled Corticosteroid Therapy: Pooled Data From the Ariel Teper (US)

13:45 - 14:00

3196: Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children | Said Arablin Oropeza (Mexico)

14:00 - 14:15

3197: Mometasone Furoate Vs Fluticasone Propionate in Mild Persistent Asthma: Retrospective Analysis of Asthma Control and Adherence Felicia Allen-Ramey (US)

Oral Abstract Session 19: Mechanisms of Allergic Inflammation

Tulum (Cancún Center)

Chairpersons: Mubeccel Akdis (Switzerland) and Hirohisa Saito (Japan)

13:00 - 13:15

3199: Type I and III Interferon Are Attenuated in a Human Invitro Model of Alternatively Activated Macrophages | Ashraf EL Fiky (US)

13:15 - 13:30

3200: A Highly Sensitive and Specific Universal Mirna Profiling Method | Jia-Wang Wang (US)

13:30 - 13:45

3201: Caspase-4 Plays a Role in the Activation of the Cryopyrin/NLRP3 Inflammasome | Ruan Cox Jr. (US)

13:45 - 14:00

3202: Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis Direction From Autoimmune Diseases | Xingnan Li (US)

14:00 - 14:15

3203: Allergy Is An Epithelial Barrier Disease | Risto Renkonen (Finland)

Oral Abstract Session 20: Patho-Biology of Nasal Polyps

Xcaret (Cancún Center)

Chairpersons: Robert Naclerio (US) and Mark Glaum (US)

12:45 - 13:00

3204: Mutiplex Analyses of Cytokine and Chemokine Release From the Cultured Fibroblast of Nasal Polyp: The Effect of IL-17A | Katsuhisa Ikeda (Japan)

13:00 - 13:15

3205: Expression of Chemokine Receptors CCR1, CCR3, CCR4, CCR5, CCR8 and CXCR3 in Human Nasal Polyps (NP); Cmparison with NP From Allergic Patients with Aspirin Intolerance | Petra Fundova (Czech Republic)

13:15 - 13:30

3206: Characterization of Two Epithelial Cell Air-Liquid Interface (ALI) Culture Models for Human Healthy Nasal Mucosa and Nasal Polyps | Fco. de Borja Callejas (Spain)

13:30 - 13:45

3207: Corticosteroid Treatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps | Fco. de Borja Callejas (Spain)

13:45 - 14:00

3208: Expression and Localization of CysLT2 Receptor In Human Nasal Mucosa | Shirasaki Hideaki (Japan)

14:00 - 14:15

3209: Increased Expression and Role of Thymic Stromal Lymphopoietin In Nasal Polyposis | Satoko Kimura (Japan)

Oral Abstract Session 21: Respiratory Infections

Costa Maya 1 (Cancún Center)

Chairpersons: Robert C. Strunk and Hyun Hee Kim (South Korea)

12:45 - 13:00

3210: Inhibition of AKT Kinase Activity Decreases Replication of Human Respiratory Syncytial Virus Michael Teng (US)

13:00 - 13:15

3211: Abnormal Immune Response Against Respiratory Pathogens In Olympic Athletes | Marcin Kurowski (Poland)

13:15 - 13:30

3212: The Immune Response Against Respiratory Pathogens in Patients with Chronic Rhinosinusitis/Nasal Polyps and Asthma with or without Sensitivity to Aspirin | Agnieszka Olszewska-Ziąber (Poland)

13:30 - 13:45

3213: Immunologic and Clinical Characteristics of Pediatric Population with Human Influenza Virus H1N1 infection in Federal Hospital of Mexico | Jaime Mellado-Abrego (Mexico)

13:45 - 14:00

3214: Evaluation of Various Forms of Sinusitis Using Bone SPECT | Sergul Ulus (Turkey)

14:00 - 14:15

3215: Rhinitis: WHERE IS the Biofilm? | Matteo Gelardi (Italy)

Oral Abstract Session 22: Rhinitis Treatment 1

Costa Maya 2 (Cancún Center)

Chairpersons: Michael S. Blaiss (US) and Teet Pullerits (Sweden)

12:45 - 13:00

3216: A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol In the Relief of Nasal Symptoms of Perennial Allergic Rhinitis John Karafilidis (US)

13:00 - 13:15

3217: 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine | Nils Achilles (Germany)

13:15 - 13:30

3218: Levels of VCAM and ICAM In Patients with Allergic Rhino-Conjunctivitis and H1 Antihistamines | Ioana Adriana Bujor (Romania)

13:30 - 13:45

3219: Once Daily Intranasal Fluticasone Furoate Decreases Daytime Sleepiness and Improves Cognitive Performance in Symptomatic Seasonal Allergic Rhinitis | Alejandro Diaz (US)

13:45 - 14:00

3220: International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR). Physicians' View | H A Badellino (Argentina)

14:00 - 14:15

3221: International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR): The Patients' View | Alvaro Teijeiro (Argentina)

Oral Abstract Session 23: Sublingual Immunotherapy 2

Auditorium (Cancún Center)

Chairpersons: Giorgio Walter Canonica (Italy) and Linda Cox (US)

12:45 - 13:00

3222: Therapeutic Effect and Safety of the Sublingual Immunotherapy with Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patiens | Raúl Lázaro Castro Almarales (Cuba)

13:00 - 13:15

3223: Candidate for Response Monitoring or Prognostic Biomarkers In Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis | Takashi Fujimura (Japan)

13:15 - 13:30

3224: Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in US Adults with Grass-Pollen Allergic Rhinoconjunctivitis | Linda Cox (US)

13:30 - 13:45

3225: Establishing the Effectiveness, Cost-Effectiveness and Safety of Oral and Sublingual Immunotherapy for Food Allergy: A Systematic Review and Meta-Analysis of Intervention Studies | Ulugbek Nurmatov (United Kingdom)

13:45 - 14:00

3226: Safety of Timothy Grass Allergy Immunotherapy Tablet In North American Adults and Children | Peter Creticos (US)

14:00 - 14:15

3227: Safety and Tolerability of Timothy Grass Allergy Immunotherapy Tablet In Adults and Children with Allergic Rhinoconjunctivitis: Post Hoc Analysis of 7 Clinical Trials | Hendrik Nolte (US)

Oral Abstract Session 24: Atopic Dermatitis 2

Gran Cancún 1 (Cancún Center)

Chairpersons: Elizabeth Estrada Reyes (Mexico) and Mona Al-Ahmad (Kuwait)

12:45 - 13:00

4159: The Risk of Atopic Dermatitis in Children Exposed to Pets During Pregnancy | Neetu Vasu (US)

13:00 - 13:15

4160: Economic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis: Results From 5 European Countries Joerg Spieldenner (Switzerland)

13:15 - 13:30

4161: Prevalence and Associated Risk Factors for Atopic Dermatitis Symptoms in Mexican Children | Eunice Sandoval-Ramírez (Mexico)

13:30 - 13:45

4162: Involvement of Human Histamine N-Methyltransferase Gene Polymorphisms in Susceptibility to Atopic Dermatitis in Korean Children Yong Ju Lee (South Korea)

13:45 - 14:00

4163: Circadian Regulation of Scratching Behavior in NC/Tnd Mice, a Mouse Model for Human Atopic Dermatitis | Keitaro Ohmori (Japan)

14:00 - 14:15

4164: Metallic Soap Aggravates Skin Conditions in Patients with Atopic Dermatitis and a Mouse Model for Human Atopic Dermatitis, NC/Tnd Mice | Akane Tanaka (Japan)

Oral Abstract Session 25: Childhood Asthma and Allergies

Gran Cancún 2 (Cancún Center)

Chairpersons: S.G.O. Johansson and Mika Mäkelä

12:45 - 13:00

4165: The Allergic March Resolved At Allergen Component Level | Giovanni Melioli (Italy)

13:00 - 13:15

4166: Prevalence of Wheezing and Risk Factors Associated to Wheezing in Infants in the First Year of Life, Cuiabá, MT, Brazil | Lillian Sanchez Lacerda Moraes (Brazil)

13:15 - 13:30

4167: Specific IgE Sensitisation In A Six-Year Old Infant Cohort In New Zealand | Rob Siebers (New Zealand)

13:30 - 13:45

4168: Risk Factors Associated to Wheezing In Mexican Children. A Multicentric ISAAC-Based Survey Study | Armando Partida-Gaytan (Mexico)

13:45 - 14:00

4169: Association Between Eosinophil Apoptosis in Induced Sputum and Asthma Severity in Children | Alla Nakonechna (United Kingdom)

14:00 - 14:15

4170: Antibiotics but Not Paracetamol Reduce the Risk for Recurrent Wheezing in Infants | Herberto Jose Chong Neto (Brazil)

Oral Abstract Session 26: Cytokines and Chemokines

Gran Cancún 3 (Cancún Center)

Chairpersons: Francesca Levi-Schaffer (Israel) and Andrew Wardlaw (United Kingdom)

12:45 - 13:00

4171: Hypoxia-Inducible Factor 1 (HIF-1) Transcription Is a “Signalling Driver” for Allergic Inflammation, Host Innate Immune Defence and Leukaemia Progression | Vadim Sumbayev (United Kingdom)

13:00 - 13:15

4172: Keratinocytic Thymic Stromal Lymphopoietin Plays An Important Role in Epicutaneous Sensitization and the Atopic March | Juan Manuel Leyva Castillo (France)

13:15 - 13:30

4173: Pivotal Role of Intestinal Interleukin-17-Producing Gammadeltat Cells In the Food Allergy | Ryusuke Nakagawa (Japan)

13:30 - 13:45

4174: Effect of Formoterol on Eosinophil Trans-Basement Migration Induced by Interleukin-8-Stimulated Neutrophils | Akiko Kawashima (Japan)

Oral Abstract Session 27: Drug Allergy

Gran Cancún 4 (Cancún Center)

Chairpersons: David Khan (US) and Luis Felipe Chiaverini Ensina (Brazil)

12:45 - 13:00

4175: Characteristics of Liver Injury in Drug-Induced Systemic Hypersensitivity Reactions | Chan Sun Park (South Korea)

13:00 - 13:15

4176: Outcomes of Reintroducing Antituberculous Drugs Following Cutaneous Adverse Drug Reactions | Rannakoe Lehloenya (South Africa)

13:15 - 13:30

4177: Penicillin - Diagnosis of Allergy | Janni Hjortlund (Denmark)

13:30 - 13:45

4178: Clinical Features and Risk Factors of Oxaliplatin Hypersensitivity in Koreans Yoon-Seok Chang (South Korea)

13:45 - 14:00

4179: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): What We Still Have to Learn? | Luciana Kase Tanno (Brazil)

Oral Abstract Session 28: Food Allergy

Gran Cancún 5 (Cancún Center)

Chairpersons: Kyu-Earn Kim (South Korea) and Sami Bahna (US)

12:45 - 13:00

4180: Glutathione Exposed Sequential Epitopes of Ovomucoid Are Relevant for Persistent Egg-Allergic Patients Tamar Kinaciyan (Austria)

13:00 - 13:15

4181: The Choice of Hypoallergens for Fish and Peach to Develop Food Allergy Specific Immunotherapy (The FAST Project) | Laurian Zuidmeer-Jongejan (Netherlands)

13:15 - 13:30

4182: IFN-ã Induces Milk Allergen-Specific IL-10-Producing Regulatory B Cells in Non -IgE Mediated Milk Allergy | Jae Ho Lee Sr. (South Korea)

13:30 - 13:45

4183: Analysis of IgE, IgE RAST Value and Prick Test in Wheat or Hen's Egg-Allergy Infants Treated with Slow Specific Oral Tolerance Induction Therapy | Takeshi Noma (Japan)

13:45 - 14:00

4184: Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy | Kiyotake Ogura (Japan)

14:00 - 14:15

4185: Factors Associated with Development of Food Allergy in Liver-Transplanted Children | Tetsuo Shoda (Japan)

Oral Abstract Session 29: Hymenoptera Allergy

Cozumel 2 (Cancún Center)

Chairpersons: James Tracy (US) and Mubeccel Akdis (Switzerland)

12:45 - 13:00

4186: Clinical Features and Diagnostic Value of Specific IgE to Component Allergen in Bee Venom Allergy in Korea | Yoo Seob Shin (South Korea)

13:00 - 13:15

4187: Is Basophil Specific Response to Hymenoptera Venom Related to T Regulatory Cells? | Petr Kucera (Czech Republic)

13:15 - 13:30

4188: Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis | Liliana Cifuentes (Germany)

13:30 - 13:45

4189: Efficacy of Venom Immunotherapy Given Every 3 or 4 MONTHS. A DIRECT Prospective COMPARISON with the Conventional REGIMEN | Livio Simioni (Italy)

13:45 - 14:00

4190: SERUM CTLA-4 and IL-10 In Hymenoptera Venom Immunotherapy: Equivalence of DIFFERENT INDUCTION Regimens | Anna Maria Riccio (Italy)

14:00 - 14:15

4191: Purification of the Allergenic Protein Hyaluronidase From the Venom of Social Wasp Polybia Paulista (Hymenoptera: Vespidae) | Débora Laís Justo Jacomini (Brazil)

Oral Abstract Session 30: Immunobiology of Allergens

Isla Mujeres (Cancún Center)

Chairpersons: Barbara Gepp (Austria) and Christian Radauer (Austria)

12:45 - 13:00

4192: High Immunogenicity of the Allergen Phl p 5 Expressed in Transgenic Mice As a Membrane-Anchored Protein | Andreas Farkas (Austria)

13:00 - 13:15

4193: Specific Recognition of the Major Birch Pollen Allergen Bet v 1 Programs Dendritic Cells to Induce Either Th2 or Tolerogenic Responses | Ursula Smole (Austria)

13:15 - 13:30

4194: Recombinant Scfv Antibodies for IgE Epitope Mapping and Detection of Parvalbumins | Merima Bublin (Austria)

13:30 - 13:45

4195: Bet v 1-Specific T-Cell Receptor/Forkhead Box Protein 3 Transgenic T-Cells Suppress Bet v 1-Specific T-Cell Effector Function in An Activation-Dependent Manner | Klaus Schmetterer (Austria)

13:45 - 14:00

4196: Grass Pollen Allergen-Induced Surface Expression of CD203c, CD63 and CD107a on CRTH2+ Basophils: Novel Biomarkers for Monitoring Efficacy of Allergen-Specific Immunotherapy | Mohamed Shamji (United Kingdom)

14:00 - 14:15

4197: Specific IgE and IgG Binding to Allergoids of Phleum Pratense | Barbara Cases (Spain)

Oral Abstract Session 31: Mechanisms of Asthma and Allergic Inflammation

Tulum (Cancún Center)

Chairpersons: Homer Boushey (US) and Elliot Israel (US)

12:45 - 13:00

4198: Heterogeneity of Allergen Epitope-Specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-Based Immunotherapy | Erik Wambre (US)

13:00 - 13:15

4199: The Association Between Mast Cells and Remodelling of the Small Airways in Chronic Asthma | Kenneth Snibson (Australia)

13:15 - 13:30

4200: Creation of a Humanized Model for Respiratory Allergy Using a Human Mugwort-Specific T-Cell Receptor and HLA-DR1 | Alina Neunkirchner (Austria)

13:30 - 13:45

4201: Eosinophils Enhance Airway Smooth Muscle Cell Proliferation Via the Release of Cysteinyl Leukotrines | Rabih Halwani (Saudi Arabia)

13:45 - 14:00

4202: Colour Change In the Human Histamine Wheal; A Sign of Desensitized Histamine Vasoconstrictory Receptors | Lars Malm (Sweden)

14:00 - 14:15

4203: Involvement of the Hypoxia-Inducible Factor-1 Transcription Complex in the Inflammatory Responses of Human Mast Cells and Basophils Vadim Sumbayev (United Kingdom)

Oral Abstract Session 32: Primary Immunodeficiency

Xcaret (Cancún Center)

Chairpersons: Hani Ababneh (Jordan) and Charlotte Cunningham-Rundles (US)

12:45 - 13:00

4204: Mycobacterial Infections In Children with Chronic Granulomatous Disease | Saul Lugo-Reyes (Mexico)

13:00 - 13:15

4205: Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-Linked Agammaglobulinemia | Maria Edith Gonzalez Serrano (Mexico)

13:15 - 13:30

4206: Hypogammaglobulinemia in a Boy: Consider Also X- Linked Lymphoproliferative Disease | Luisa Gamez (Mexico)

13:30 - 13:45

4207: Transmission Pattern and Carriers Identification in Male Patients with Chronic Granulomatous Disease | Blancas-Galicia Lizbeth (Mexico)

13:45 - 14:00

4207A: Genetic Association Study of the IgE Immunodeficiency in Mexican Population | Jose Augusto Malpica Cruz (Mexico)

14:00 - 14:15

4208: CD21-/Low B Cells Are Increased in Both Common Variable Immune Deficiency (CVID) and Specific Antibody Deficiency (SAD) | Araceli Elizalde (US)

Oral Abstract Session 33: Rhinitis Treatment 2

Costa Maya 1 (Cancún Center)

Chairpersons: Joaquim Mullol (Spain) and James Baraniuk (US)

12:45 - 13:00

4209: Patterns of Initiation and Adherence to De Novo Allergen-Specific Immunotherapy Among Adults and Children with Newly-Diagnosed Allergic Rhinitis: Findings From Research Jointly Funded by the AAAAI and ACAAI | Cheryl Hankin (US)

13:00 - 13:15

4210: Effect of Simvastatin on Transforming Growth Factor Beta-1-Induced Myofibroblast Differentiation and Collagen Production in Nasal Polyp-Derived Fibroblasts | Il-Ho Park (South Korea)

13:15 - 13:30

4211: Onset of Action of MP29-02 in the Treatment of Seasonal Allergic Rhinitis | Jonathan Bernstein (US)

13:30 - 13:45

4212: MP29-02 in the Treatment of Nasal Symptoms of Seasonal Allergic Rhinitis | William Wheeler (US)

13:45 - 14:00

4213: A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects with Perennial Allergic Rhinitis John Karafilidis (US)

14:00 - 14:15

4214: Omalizumab Improves Asthma but Not Nasal Symptoms in Japanese Patients with Severe Allergic Asthma and Rhinitis | Fuyumi Nishihara (Japan)

Oral Abstract Session 34: Allergen Immunotherapy 2

Costa Maya 2 (Cancún Center)

Chairpersons: Lars Jacobsen (Denmark) and Guillermo Salamanca (Spain)

12:45 - 13:00

4215: Efficacy and Safety of Ragweed Allergy Immunotherapy Tablet in Multisensitized North American Adults: Preliminary Findings | Peter Creticos (US)

13:00 - 13:15

4216: Comparison of Efficacy and Safety of A Depigmented Polymerized Allergen Extract of Grass and Birch with Placebo In Patients with Type-I Allergic Rhinoconjunctivitis | Angelika Sager (Germany)

13:15 - 13:30

4217: Allergenic Composition of Polymerized Allergen Extracts of Betula Verrucosa, Dermatophagoides Pteronyssinus and Phleum Pratense | Enrique Fernandez-Caldas (Spain)

13:30 - 13:45

4218: A Proteomic Style Approach to Characterise a Grass Mix Product Reveals Potential Immunotherapeutic Benefit Alan Bullimore (United Kingdom)

13:45 - 14:00

4219: Seasonal Vs. Symptom-Based Evaluation of A Depigmented Grass-Birch Allergoid | Oliver Pfaar (Germany)

14:00 - 14:15

4220: Efficacy and Tolerability of HDM Injective Immunotherapy with Monomeric Allergoid | Enrico Compalati (Italy)

Oral Abstract Session

Monday, 5 December 2011

12:45 - 14:15

Tuesday, 6 December 2011

12:45 - 14:15

Wednesday, 7 December 2011

12:45 - 14:15